HomeProductsBioactive CompoundsCytoskeletonIntegrinCilengitide
Chemical structure of CAS 188968-51-6

Cilengitide

In Stock•Starting at $19 for 1 mg•Purity ≥ 98%
CAS No.188968-51-6
MDL No.MFCD04307743
MFC27H40N8O7
MW588.70
InChI KeyAMLYAMJWYAIXIA-VWNVYAMZSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98%$19In Stock
25 mg98%$103In Stock
50 mg98%$171In Stock
100 mg98%$301In Stock
250 mg98%$509In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Cilengitide is an oligopeptide.

CAS No.188968-51-6
Product NameCilengitide

Biological Targets

ITGB3·ITGAV·ITGB5

Associated Conditions

male breast carcinoma·myelodysplastic syndrome·prostate cancer·diffuse intrinsic pontine glioma·melanoma·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Cilengitide (EMD 121974) arrests the growth of a heavily pretreated highly vascularised head and neck tumour.

Oral oncology • Vol. 40, Issue 2 • 2004
PMID: 14693249DOI: 10.1016/j.oraloncology.2003.08.003

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology • Vol. 25, Issue 1 • 2003
PMID: 12690708

Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins alphavbeta3 and alphavbeta5 in patients with advanced solid tumours.

European journal of cancer (Oxford, England : 1990) • Vol. 39, Issue 7 • 2003
PMID: 12706360DOI: 10.1016/s0959-8049(03)00057-1

Alpha v integrin inhibitors and cancer therapy.

Current opinion in investigational drugs (London, England : 2000) • Vol. 4, Issue 6 • 2003
PMID: 12901232

Documentation

Similar Products